RINICARE LTD THE INTELLIGENT HEALTHCARE COMPANY ANNOUNCES NEW APPOINTMENT OF NEW CHAIRMAN
Rinicare appoints Duane Lawrence as non-executive chairman to support the company’s growth and commercialisation of its AI portfolio.
Manchester, UK, 25th July 2019 – Rinicare Limited a leading intelligent healthcare company announced today the appointment of Duane Lawrence as non-executive chairman. Duane has 30 years’ experience of leading healthcare technology businesses across five continents. Throughout his career he has specialised in recognising talent, building strong teams, recognising emerging opportunities in global markets and building programmes and products to successfully fill those opportunities. From 2015 to 2017, he was Managing Director at EMIS Health, one of the leading UK headquartered global HealthTech software and services business. Prior to that, he was the CEO of InferMed Ltd, a clinically focused decision support technology start up, having joined the Board in May 2007 and leading it through to its successful trade exit in 2015. Duane and his family moved to the UK permanently in 2003 to take over as General Manager of Misys Healthcare Systems International Ltd, with responsibility for the company’s healthcare operations outside of North America. His successful track record of global commercial leadership will be of significant benefit to Rinicare. Duane is a business and finance graduate of the University of Notre Dame in the USA.
Stuart Hendry, CEO of Rinicare commented: “We are very pleased to welcome Duane to Rinicare’s board, his experience in the digital health space will be invaluable as we accelerate the commercialisation of our AI, ML programmes based on are unique and rapidly expanding data lake, which are set to radically improve healthcare costs and outcomes for our customers.”
Duane Lawrence said “It’s an honour to join Stuart and the team at Rinicare at such a critical time in their growth. I look forward to doing my part to help them accelerate their pace and make a significant difference in the lives of millions around the world.”
For further information, please contact:
Dr Stuart Hendry, Chief Executive Officer – +44 (0)1615 37 59 29